Telbivudine for the treatment of chronic hepatitis B

  • Technology appraisal guidance
  • TA154
  • Published: 
Download guidance (PDF)

1 Guidance

This guidance does not apply to people with chronic hepatitis B who also have hepatitis C, hepatitis D or HIV.

1.1 Telbivudine is not recommended for the treatment of chronic hepatitis B.

1.2 People currently receiving telbivudine should have the option to continue therapy until they and their clinicians consider it appropriate to stop.

  • National Institute for Health and Care Excellence (NICE)